Diketopiperazines (DKPs) make up a large group of natural products with diverse structures and biological activities. Bicyclomycin is a broad-spectrum DKP antibiotic with unique structure and function: it contains a highly oxidized bicyclic [4.2.2] ring and is the only known selective inhibitor of the bacterial transcription termination factor, Rho. Here, we identify the biosynthetic gene cluster for bicyclomycin containing six iron-dependent oxidases. We demonstrate that the DKP core is made by a tRNA-dependent cyclodipeptide synthase, and hydroxylations on two unactivated sp3 carbons are performed by two mononuclear iron, α-ketoglutarate-dependent hydroxylases. Using bioinformatics, we also identify a homologous gene cluster prevalent in a human pathogen Pseudomonas aeruginosa. We detect bicyclomycin by overexpressing this gene cluster and establish P. aeruginosa as a new producer of bicyclomycin. Our work uncovers the biosynthetic pathway for bicyclomycin and sheds light on the intriguing oxidation chemistry that converts a simple DKP into a powerful antibiotic.
Diketopiperazines (n class="Chemical">DKPs) make up a large group of natural products with diverse structures and biological activities. Bicyclomycin is a broad-spectrum DKP antibiotic with unique structure and function: it contains a highly oxidized bicyclic [4.2.2] ring and is the only known selective inhibitor of the bacterial transcription termination factor, Rho. Here, we identify the biosynthetic gene cluster for bicyclomycin containing six iron-dependent oxidases. We demonstrate that the DKP core is made by a tRNA-dependent cyclodipeptide synthase, and hydroxylations on two unactivated sp3 carbons are performed by two mononuclear iron, α-ketoglutarate-dependent hydroxylases. Using bioinformatics, we also identify a homologous gene cluster prevalent in a human pathogen Pseudomonas aeruginosa. We detect bicyclomycin by overexpressing this gene cluster and establish P. aeruginosa as a new producer of bicyclomycin. Our work uncovers the biosynthetic pathway for bicyclomycin and sheds light on the intriguing oxidation chemistry that converts a simple DKP into a powerful antibiotic.
Authors: N Misawa; M Sueyoshi; R Uemura; Y Kakemizu; K Kawashima; H Nagatomo; F Kondo; T Murakami; Y Takahashi Journal: Microbiol Immunol Date: 2000 Impact factor: 1.955
Authors: Daniel H Scharf; Thorsten Heinekamp; Nicole Remme; Peter Hortschansky; Axel A Brakhage; Christian Hertweck Journal: Appl Microbiol Biotechnol Date: 2011-11-18 Impact factor: 4.813
Authors: Vikram V Shende; Yogan Khatri; Sean A Newmister; Jacob N Sanders; Petra Lindovska; Fengan Yu; Tyler J Doyon; Justin Kim; K N Houk; Mohammad Movassaghi; David H Sherman Journal: J Am Chem Soc Date: 2020-09-30 Impact factor: 15.419
Authors: Natalia M Vior; Rodney Lacret; Govind Chandra; Siobhán Dorai-Raj; Martin Trick; Andrew W Truman Journal: Appl Environ Microbiol Date: 2018-04-16 Impact factor: 5.005